FUHRMANN ULRIKE
No ORCID on file
· 25 papers in corpus
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
other
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2009
2009
2009
The aim of the present invention is the use of mineralcorticoid receptor antagonists for the production of a drug for the treatment of endometriosis. The present invention particularly relates to an improved therapeutic agent against endome…
other
2009
Amide compounds (I), are new. Amide compounds of formula (I), are new. q : 0 or 1 R 1>mono or bicyclic 6-12C aryl, 5-12 membered hetero aryl, 3-10C cycloalkyl, or 3-10 membered hetero cycloalkyl residue, which is unsubstituted or substitute…
2009
The present invention relates to non-steroidal progesterone receptor modulators of the general formula 1, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise the…
2009
The present invention relates to non-steroidal progesterone receptor modulators of the general formula I the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compositions which comprise these compoun…
2009
The present invention relates to nonsteroidal progesterone receptor modulators of the general formula (I), to the use of the progesterone receptor modulators for the preparation of pharmaceuticals, and to pharmaceutical compositions compris…
2008
This invention relates to nonsteroidal progesterone receptor modulators of general formula (I), a process for their production, the use of progesterone receptor modulators for the production of pharmaceutical agents as well as pharmaceutica…
2008
This invention relates to nonsteroidal progesterone receptor modulators of general formula (I), a process for their production, the use of progesterone receptor modulators for the production of pharmaceutical agents as well as pharmaceutica…
other
2008
The mineralcorticoid receptor antagonist comprises spironolactone, eplerenone and drospirenone. Glucocorticoid, progesterone receptor antagonist and estrogen receptor antagonist are also included. The estrogen is ethinylestradiol. - ACTIVIT…
2008
2008
The aim of the present invention is the use of mineralcorticoid receptor antagonists for the production of a drug for the treatment of endometriosis. The present invention particularly relates to an improved therapeutic agent against endome…
other
2008
The aim of the present invention is the use of mineralcorticoid receptor antagonists for the production of a drug for the treatment of endometriosis. The present invention particularly relates to an improved therapeutic agent against endome…
other
2008
Amide compounds (I), are new. Amide compounds of formula (I), are new. A : H, Z substituted 1-8C-alkyl, 2-8C-alkenyl, 2-8C alkinyl, M substituted 3-10C-cycloalkyl, 3-12-membered heterocycloalkyl residue, where Z is cyano, halogen, hydroxy, …
2008
The present invention relates to non-steroidal progesterone receptor modulators of the general formula (I), a process for their preparation, the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compo…
other
2008
The invention relates to non-steroidal progesterone receptor modulators of general formula (I), use of the progesterone receptor modulators for the production of medicaments and pharmaceutical compositions containing said compounds. Said co…
other
2008
The invention relates to non-steroidal progesterone receptor modulators of general formula (I), use of the progesterone receptor modulators for the production of medicaments and pharmaceutical compositions containing said compounds. Said co…
other
2008
The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise the…
other
2008
The present invention relates to non-steroidal progesterone receptor modulators of the general formula (I), a process for their preparation, the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compo…
2006
This invention relates to nonsteroidal progesterone receptor modulators of general formula (I), a process for their production, the use of progesterone receptor modulators for the production of pharmaceutical agents as well as pharmaceutica…
2006
This invention relates to nonsteroidal progesterone receptor modulators of general formula (I), a process for their production, the use of progesterone receptor modulators for the production of pharmaceutical agents as well as pharmaceutica…
2006
The present invention relates to non-steroidal progesterone receptor modulators of the general formula (I), a process for their preparation, the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compo…
2006
The present invention relates to non-steroidal progesterone receptor modulators of the general formula (I), a process for their preparation, the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compo…